rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
22
|
pubmed:dateCreated |
2011-7-29
|
pubmed:abstractText |
To evaluate risk factors for outcome in children and adolescents with relapse of anaplastic large-cell lymphoma (ALCL) after comparable first-line therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AttarbaschiAndisheA,
pubmed-author:BurkhardtBirgitB,
pubmed-author:KlapperWolframW,
pubmed-author:KremensBernhardB,
pubmed-author:LenhardMeikeM,
pubmed-author:MannGeorgG,
pubmed-author:OschliesIlskeI,
pubmed-author:ReiffTT,
pubmed-author:ReiterAlfredA,
pubmed-author:RossigClaudiaC,
pubmed-author:WoessmannWilliW,
pubmed-author:ZimmermannMartinM
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3065-71
|
pubmed:meshHeading |
pubmed-meshheading:21709186-Adolescent,
pubmed-meshheading:21709186-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21709186-Child,
pubmed-meshheading:21709186-Child, Preschool,
pubmed-meshheading:21709186-Disease-Free Survival,
pubmed-meshheading:21709186-Feasibility Studies,
pubmed-meshheading:21709186-Female,
pubmed-meshheading:21709186-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:21709186-Humans,
pubmed-meshheading:21709186-Immunohistochemistry,
pubmed-meshheading:21709186-Immunophenotyping,
pubmed-meshheading:21709186-Lymphoma, Large-Cell, Anaplastic,
pubmed-meshheading:21709186-Male,
pubmed-meshheading:21709186-Predictive Value of Tests,
pubmed-meshheading:21709186-Prognosis,
pubmed-meshheading:21709186-Recurrence,
pubmed-meshheading:21709186-Remission Induction,
pubmed-meshheading:21709186-Risk Assessment,
pubmed-meshheading:21709186-Risk Factors,
pubmed-meshheading:21709186-Salvage Therapy,
pubmed-meshheading:21709186-Transplantation, Autologous,
pubmed-meshheading:21709186-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
|
pubmed:affiliation |
NHL-BFM Study Center and Department of Pediatric Hematology and Oncology, Justus-Liebig-University, D-35392 Giessen, Germany. Wilhelm.woessmann@paediat.med.uni-giessen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|